Trial Site Detail
Drug: |
BGT226 |
|||
|---|---|---|---|---|
Trial: |
A Phase I/II Study of BGT226 in Adult Patients With Advanced Solid Malignancies Including Patients With Advanced Breast Cancer |
|||
| Conditions: | Solid Tumors | |||
Trial Status: |
Completed |
|||
Nevada Cancer Institute10441 W Twain Ave |
Principal Investigator: |
Lin-Chi Chen, M.D., Ph.D. |
|---|---|
Contact: |
Dianna Tercan (702) 822-5483 |
Activation Status of this Site: |
Closed |
Notes about this Site: |
|
Nevada Cancer Institute Website: |
Navigating the Map
Use the plus (+) and minus (-) controls to zoom in/out.
Click and drag the map or use the arrows to move (pan) the map.
Tip: Click the marker before zooming and the map will stay centered on the marker as you zoom.